Broken biotech at a ~35% discount to net cash. ESSA is engaged in a strategic review and has no ongoing operations. Activist involvement from Tang Capital points to a sale in the near future
Great write-up Rohan! Once again thank you.
Do you happen to know why the stock is soring today roughly 10%? I cannot find any news supporting that drastic move. Thank you!
Thanks Enrique, appreciate it! I believe the move today likely has something to do with the Soleus Capital filing (https://www.sec.gov/Archives/edgar/data/1633932/000121390025032152/0001213900-25-032152-index.htm). I posted a quick note about this here: https://substack.com/@rohansoor/note/c-109098905
Thank you so much, Rohan. I learn a lot through your write-ups and comments, really appreciate it
Great read!!
Thank you!
Great write-up Rohan! Once again thank you.
Do you happen to know why the stock is soring today roughly 10%? I cannot find any news supporting that drastic move. Thank you!
Thanks Enrique, appreciate it! I believe the move today likely has something to do with the Soleus Capital filing (https://www.sec.gov/Archives/edgar/data/1633932/000121390025032152/0001213900-25-032152-index.htm). I posted a quick note about this here: https://substack.com/@rohansoor/note/c-109098905
Thank you so much, Rohan. I learn a lot through your write-ups and comments, really appreciate it
Great read!!
Thank you!